BR9809112A - Novo processo para preparação de uma substância farmacologicamente ativa - Google Patents

Novo processo para preparação de uma substância farmacologicamente ativa

Info

Publication number
BR9809112A
BR9809112A BR9809112-3A BR9809112A BR9809112A BR 9809112 A BR9809112 A BR 9809112A BR 9809112 A BR9809112 A BR 9809112A BR 9809112 A BR9809112 A BR 9809112A
Authority
BR
Brazil
Prior art keywords
active substance
pharmacologically active
new process
preparation
generic formula
Prior art date
Application number
BR9809112-3A
Other languages
English (en)
Other versions
BR9809112B1 (pt
Inventor
Maria Bakonyi
Marianna Csatarine Nagy
Leventene Molnar
Antal Gajary
Edit Alattyani
Original Assignee
Sanofi Synthelabo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Inc filed Critical Sanofi Synthelabo Inc
Publication of BR9809112A publication Critical patent/BR9809112A/pt
Publication of BR9809112B1 publication Critical patent/BR9809112B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

"NOVO PROCESSO PARA PREPARAçãO DE UMA SUBSTâNCIA FARMACOLOGICAMENTE ATIVA" Trata-se de um processo para preparação de [2(2-tienil) -etil-amino]-(2-halogeno-fenil) -acetatos de metila da fórmula genérica (VI), partindo das acetamidas de fórmula genérica (VII). Existem ingredientes farmaceuticamente ativos valiosos, com efeito antitrombótico, entre os compostos da fórmula genérica (VI).
BRPI9809112-3A 1997-05-13 1998-05-11 processo para preparação de clopidogrel. BR9809112B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700885A HU222283B1 (hu) 1997-05-13 1997-05-13 Eljárás tieno[3,2-c]piridin-származékok előállítására
PCT/HU1998/000048 WO1998051689A1 (en) 1997-05-13 1998-05-11 A new process for the preparation of a pharmacologically active substance

Publications (2)

Publication Number Publication Date
BR9809112A true BR9809112A (pt) 2000-08-01
BR9809112B1 BR9809112B1 (pt) 2010-10-05

Family

ID=90014236

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9809112-3A BR9809112B1 (pt) 1997-05-13 1998-05-11 processo para preparação de clopidogrel.

Country Status (38)

Country Link
US (1) US6180793B1 (pt)
EP (1) EP0981529B1 (pt)
KR (1) KR100428238B1 (pt)
CN (1) CN1109036C (pt)
AR (1) AR014349A1 (pt)
AT (1) ATE212025T1 (pt)
AU (1) AU735702B2 (pt)
BR (1) BR9809112B1 (pt)
CA (1) CA2289623C (pt)
CO (1) CO4950564A1 (pt)
CZ (1) CZ292820B6 (pt)
DE (1) DE69803176T2 (pt)
DK (1) DK0981529T3 (pt)
DZ (1) DZ2487A1 (pt)
EE (1) EE03925B1 (pt)
EG (1) EG21973A (pt)
ES (1) ES2172141T3 (pt)
HK (1) HK1027350A1 (pt)
HR (1) HRP980240B1 (pt)
HU (1) HU222283B1 (pt)
ID (1) ID23018A (pt)
IL (1) IL132774A0 (pt)
IS (1) IS1883B (pt)
ME (1) ME01636B (pt)
MY (1) MY121299A (pt)
NO (1) NO325419B1 (pt)
NZ (1) NZ501577A (pt)
PL (1) PL194859B1 (pt)
PT (1) PT981529E (pt)
RS (1) RS49626B (pt)
RU (1) RU2172315C1 (pt)
SA (1) SA98190583B1 (pt)
SK (1) SK283700B6 (pt)
TR (1) TR199902783T2 (pt)
TW (1) TW552263B (pt)
UA (1) UA66359C2 (pt)
WO (1) WO1998051689A1 (pt)
ZA (1) ZA983921B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
HU226421B1 (en) 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
IN191030B (pt) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
AU2003238664A1 (en) 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
DE602004025267D1 (de) 2003-11-03 2010-03-11 Cadila Healthcare Ltd Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
KR100553398B1 (ko) 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
MX2007010267A (es) * 2005-02-24 2007-09-11 Teva Pharma Base de clopidogrel adecuada para formulacion farmaceutica y preparacion de ella.
KR100681512B1 (ko) 2005-03-08 2007-02-09 주식회사 한서켐 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
CN102014899A (zh) * 2006-04-27 2011-04-13 因-斯韦特实验室有限公司 硫酸氢氯吡格雷多晶型物的制备方法
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
US8247558B2 (en) 2006-09-04 2012-08-21 Ranbaxy Laboratories Limited Process for the preparation of clopidogrel and its pharmaceutically acceptable salts
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
CN102186858A (zh) * 2008-10-24 2011-09-14 桑多斯股份公司 制备s-氯吡格雷的方法
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101544655B (zh) * 2009-05-05 2012-07-04 上海医药集团股份有限公司 噻吩并[3，2-c]吡啶衍生物的制备方法
CN101863899B (zh) * 2010-06-21 2013-03-20 常州制药厂有限公司 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法
KR20170004283A (ko) 2015-07-02 2017-01-11 류종렬 그립부가 개선된 쉐이크 핸드형 탁구 라켓
KR20170004282A (ko) 2015-07-02 2017-01-11 류종렬 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
DE69803176T2 (de) 2002-08-22
PT981529E (pt) 2002-06-28
CZ393999A3 (cs) 2000-04-12
CN1255924A (zh) 2000-06-07
ATE212025T1 (de) 2002-02-15
IS5244A (is) 1999-11-11
KR20010012511A (ko) 2001-02-15
PL336693A1 (en) 2000-07-03
EE9900488A (et) 2000-06-15
CN1109036C (zh) 2003-05-21
JP2001525819A (ja) 2001-12-11
SK283700B6 (sk) 2003-12-02
ZA983921B (en) 1998-11-09
IL132774A0 (en) 2001-03-19
WO1998051689A1 (en) 1998-11-19
RS49626B (sr) 2007-08-03
RU2172315C1 (ru) 2001-08-20
NO325419B1 (no) 2008-04-21
EP0981529A1 (en) 2000-03-01
ME01636B (me) 2007-08-03
PL194859B1 (pl) 2007-07-31
US6180793B1 (en) 2001-01-30
EG21973A (en) 2002-05-31
NZ501577A (en) 2001-10-26
KR100428238B1 (ko) 2004-04-30
HUP9700885A2 (hu) 1999-09-28
TW552263B (en) 2003-09-11
EE03925B1 (et) 2002-12-16
CO4950564A1 (es) 2000-09-01
SK151699A3 (en) 2000-07-11
HUP9700885D0 (en) 1997-07-28
TR199902783T2 (xx) 2000-04-21
NO995533D0 (no) 1999-11-12
UA66359C2 (uk) 2004-05-17
MY121299A (en) 2006-01-28
HU222283B1 (hu) 2003-05-28
AU7444898A (en) 1998-12-08
DE69803176D1 (de) 2002-02-21
HK1027350A1 (en) 2001-01-12
HRP980240A2 (en) 1999-02-28
EP0981529B1 (en) 2002-01-16
HUP9700885A3 (en) 2000-06-28
AU735702B2 (en) 2001-07-12
CA2289623C (en) 2007-01-30
DK0981529T3 (da) 2002-04-22
NO995533L (no) 1999-12-13
JP4256478B2 (ja) 2009-04-22
IS1883B (is) 2003-08-15
HRP980240B1 (en) 2003-02-28
CA2289623A1 (en) 1998-11-19
CZ292820B6 (cs) 2003-12-17
SA98190583B1 (ar) 2006-08-19
BR9809112B1 (pt) 2010-10-05
AR014349A1 (es) 2001-02-28
ID23018A (id) 1999-12-30
ES2172141T3 (es) 2002-09-16
DZ2487A1 (fr) 2004-07-30
YU58799A (sh) 2002-06-19

Similar Documents

Publication Publication Date Title
BR9809112A (pt) Novo processo para preparação de uma substância farmacologicamente ativa
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
DK0840603T3 (da) Farmaceutisk præparat af L-dopa-ethylester
ATE306261T1 (de) Antithrombosemittel
IL133623A0 (en) Antithrombotic agents
FI872379A (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
KR960701049A (ko) 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use)
IL115746A (en) Polyanionic benzylglcosides and pharmaceutical compositions containing them
BR9809113A (pt) Novos intermediários e processo para sua preparação
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
IL115747A0 (en) Polyanionic benzylglycosides of benzene triacid amides and pharmaceutical compositions containing them
ES556552A0 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
ES2122387T3 (es) Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina.
TR199900013T2 (xx) Yeni bile�ikler.
EA200101180A1 (ru) Производные тио-оксиндола
CA2235053A1 (fr) Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta¬a|naphtalene et du 2,3-dihydro-cyclopenta, ¬e|indene, leur procede de preparation et les compositions pharmaceutiques quiles contiennent
ES2186639T3 (es) Nuevos derivados de ((2-sustituido-5-(3-tienil))-bencil)-(2-((2-isopropoxi-5-fluoro)-fenoxi)-etil)-amina, su procedimiento de preparacion y su utilizacion como medicamentos.
KR900007811A (ko) 1-아미노알킬-3옥시치환된-4-아릴-1,3,4,5-테트라하이드로-2h-1.3-벤조디아제핀-2-은, 이의 제조방법 및 이의 약제로서의 용도
PT89356A (pt) Processo para a preparacao de derivados da 2-amino-tetra-hidro-isoquinolina e de composicoes farmaceuticas contendo os mesmos
BR0016737A (pt) 14,15-ciclopropano-androstanos insaturados, processos para a sua preparação e composições farmacêuticas contendo estes compostos
EP0310969A3 (en) Pyrido-benzothiazine derivatives having high antibacterial activity and high bioavailability to tissues
CA2241788A1 (fr) Nouveaux derives de n-(arylsulfonyl)aminoacides, leur procede de preparation et compositions pharmaceutiques en contenant

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: DESCONHECO A PETICAO 020070166894 DE 26/11/2007, DE CUMPRIMENTO DE EXIGENCIA PUBLICADA NA RPI 1913DE 04/09/2007, TENHO EM VISTA QUE O INTERESSADO " DANIEL AND CIA " NAO E REPRESENTANTE LEGAL DO REFERIDO PEDIDO

B12F Other appeals [chapter 12.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/10/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 05.10.2020